Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
83.34
Dollar change
0.00
Percentage change
0.00
%
IndexRUT P/E- EPS (ttm)-0.91 Insider Own8.81% Shs Outstand100.11M Perf Week17.31%
Market Cap9.11B Forward P/E- EPS next Y-1.51 Insider Trans-4.97% Shs Float99.72M Perf Month-2.01%
Income-85.89M PEG- EPS next Q-0.28 Inst Own69.30% Short Float11.17% Perf Quarter335.42%
Sales0.00M P/S- EPS this Y-23.39% Inst Trans-0.29% Short Ratio1.72 Perf Half Y598.87%
Book/sh3.48 P/B23.95 EPS next Y-34.44% ROA-31.99% Short Interest11.14M Perf Year813.82%
Cash/sh3.31 P/C25.17 EPS next 5Y40.00% ROE-34.79% 52W Range8.28 - 99.41 Perf YTD347.82%
Dividend Est.- P/FCF- EPS past 5Y-18.89% ROI-24.59% 52W High-16.17% Beta1.05
Dividend TTM- Quick Ratio19.19 Sales past 5Y0.00% Gross Margin- 52W Low906.52% ATR (14)7.98
Dividend Ex-Date- Current Ratio19.19 EPS Y/Y TTM-2.06% Oper. Margin0.00% RSI (14)65.18 Volatility8.54% 10.94%
Employees27 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.09 Target Price104.17
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q3.76% Payout- Rel Volume0.00 Prev Close83.34
Sales Surprise- EPS Surprise1.57% Sales Q/Q- EarningsFeb 07 AMC Avg Volume6.47M Price83.34
SMA2012.50% SMA5071.25% SMA200259.55% Trades Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Mar-26-24Reiterated Oppenheimer Outperform $116 → $138
Mar-07-24Initiated Jefferies Buy $110
Feb-28-24Reiterated Oppenheimer Outperform $46 → $116
May-31-23Resumed ROTH MKM Buy $32
Mar-28-23Reiterated Maxim Group Buy $15 → $25
Mar-17-23Initiated Stifel Buy $22
Jul-29-21Resumed BTIG Research Buy $20
May-25-21Downgrade Raymond James Strong Buy → Outperform $27 → $12
Jun-05-20Initiated BMO Capital Markets Outperform $14
May-05-20Initiated Chardan Capital Markets Buy $15
Today 05:50AM
Mar-27-24 12:42PM
12:22PM
Mar-26-24 04:15PM
01:25PM
01:02PM Loading…
01:02PM
12:59PM
11:58AM
11:28AM
11:17AM
11:15AM
11:13AM
10:57AM
10:07AM
08:06AM
07:12AM Loading…
07:12AM
07:09AM
07:03AM
05:51AM
04:11AM
Mar-25-24 06:25AM
Mar-24-24 09:15AM
Mar-23-24 05:53AM
Mar-22-24 04:55AM
Mar-21-24 08:49AM
Mar-20-24 08:30AM
08:00AM
Mar-19-24 09:45AM
Mar-17-24 09:15AM
08:50AM
08:17AM Loading…
Mar-16-24 08:17AM
Mar-15-24 09:45AM
05:50AM
Mar-14-24 09:38AM
Mar-13-24 07:35AM
05:03AM
Mar-11-24 06:53AM
Mar-09-24 04:47PM
Mar-08-24 01:03PM
06:47AM
Mar-07-24 12:05PM
Mar-06-24 05:50AM
Mar-05-24 11:16AM
06:15AM
Mar-04-24 04:45PM
05:58AM
Mar-03-24 09:35AM
07:41AM
Mar-01-24 05:59PM
12:11PM
07:31AM
Feb-29-24 02:21PM
09:00AM
07:45AM
06:42AM
06:00AM
04:53AM
Feb-28-24 08:50PM
04:56PM
12:23PM
11:23AM
11:01AM
10:00AM
07:30AM
Feb-27-24 10:15PM
06:01PM
05:35PM
04:22PM
04:19PM
04:06PM
03:50PM
11:21AM
09:47AM
09:39AM
08:15AM
08:14AM
07:22AM
07:13AM
07:03AM
Feb-21-24 09:21AM
Feb-15-24 11:57AM
Feb-14-24 02:43PM
Feb-10-24 09:02AM
Feb-09-24 02:21AM
Feb-08-24 04:01PM
01:15PM
10:39AM
06:48AM
Feb-07-24 04:47PM
04:05PM
Feb-02-24 02:15AM
Feb-01-24 03:02PM
Jan-31-24 04:05PM
03:01AM
Jan-29-24 02:59AM
Jan-22-24 01:29AM
Jan-19-24 11:01PM
Jan-09-24 11:01PM
Jan-05-24 09:02AM
Jan-02-24 08:09AM
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lian BrianPresident & CEOFeb 09 '24Sale29.9045,0001,345,5002,139,882Feb 09 08:59 PM
Lian BrianPresident & CEOFeb 08 '24Option Exercise3.76189,079711,3672,404,882Feb 08 07:40 PM
Rouan Sarah KathrynDirectorFeb 08 '24Option Exercise8.3225,000208,00025,000Feb 08 07:38 PM
Lian BrianPresident & CEOFeb 08 '24Sale26.87269,0797,230,7842,184,882Feb 08 07:40 PM
Rouan Sarah KathrynDirectorFeb 08 '24Sale28.0525,000701,2500Feb 08 07:38 PM
Lian BrianPresident & CEOJan 31 '24Option Exercise1.2385,000104,5502,349,882Jan 31 08:39 PM
Lian BrianPresident & CEOJan 31 '24Sale24.7185,0002,100,7502,264,882Jan 31 08:39 PM
Lian BrianPresident & CEOJan 30 '24Option Exercise1.2335,00043,0502,299,882Jan 30 09:05 PM
Lian BrianPresident & CEOJan 30 '24Sale23.9535,000838,2502,264,882Jan 30 09:05 PM
Rouan Sarah KathrynDirectorJan 19 '24Option Exercise8.3230,000249,60030,000Jan 19 08:35 PM
Rouan Sarah KathrynDirectorJan 19 '24Sale23.0530,000691,5000Jan 19 08:35 PM
ZANTE GREGChief Financial OfficerJan 04 '24Sale17.9015,000268,500180,730Jan 04 09:35 PM
Rowland Charles A JrDirectorMay 16 '23Option Exercise1.0840,00043,20070,000May 18 06:31 PM
MACARTNEY LAWSONDirectorMay 16 '23Option Exercise1.1916,00019,04063,965May 18 06:30 PM
Rowland Charles A JrDirectorMay 16 '23Sale25.0040,0001,000,00030,000May 18 06:31 PM
MACARTNEY LAWSONDirectorMay 16 '23Sale24.0016,000384,00047,965May 18 06:30 PM
Lian BrianPresident & CEOMay 01 '23Sale22.4545,0001,010,2502,197,963May 01 07:03 PM
MACARTNEY LAWSONDirectorApr 24 '23Option Exercise3.3316,00053,28063,965Apr 24 07:31 PM
MACARTNEY LAWSONDirectorApr 24 '23Sale22.0016,000352,06147,965Apr 24 07:31 PM
Lian BrianPresident & CEOApr 19 '23Sale21.4535,000750,7502,242,963Apr 21 07:29 PM
Lian BrianPresident & CEOApr 17 '23Option Exercise2.15125,000268,7502,432,963Apr 18 07:09 PM
MACARTNEY LAWSONDirectorApr 17 '23Option Exercise8.0020,786166,28868,751Apr 18 07:10 PM
Mancini MariannaChief Operating OfficerApr 17 '23Option Exercise13.0712,500163,375300,263Apr 18 07:08 PM
ZANTE GREGChief Financial OfficerApr 17 '23Option Exercise13.077,50098,025156,779Apr 18 07:07 PM
Lian BrianPresident & CEOApr 17 '23Sale20.45155,0003,169,7662,277,963Apr 18 07:09 PM
MACARTNEY LAWSONDirectorApr 17 '23Sale20.0020,786415,72047,965Apr 18 07:10 PM
Mancini MariannaChief Operating OfficerApr 17 '23Sale20.0012,500250,000287,763Apr 18 07:08 PM
ZANTE GREGChief Financial OfficerApr 17 '23Sale20.007,500150,000149,279Apr 18 07:07 PM
Lian BrianPresident & CEOApr 13 '23Option Exercise1.8854,336102,1522,387,299Apr 13 05:14 PM
Lian BrianPresident & CEOApr 13 '23Sale18.4579,3361,463,7492,307,963Apr 13 05:14 PM
ZANTE GREGChief Financial OfficerApr 12 '23Option Exercise5.9941,544249,026190,823Apr 13 05:13 PM
ZANTE GREGChief Financial OfficerApr 12 '23Sale18.0041,544747,792149,279Apr 13 05:13 PM
ZANTE GREGChief Financial OfficerApr 11 '23Option Exercise5.2556,295295,778205,574Apr 13 05:13 PM
ZANTE GREGChief Financial OfficerApr 11 '23Sale18.0056,2951,013,518149,279Apr 13 05:13 PM
ZANTE GREGChief Financial OfficerApr 03 '23Option Exercise7.7730,911240,178178,689Apr 03 07:24 PM
ZANTE GREGChief Financial OfficerApr 03 '23Sale18.0030,911556,398147,778Apr 03 07:24 PM
Lian BrianPresident & CEOApr 03 '23Sale17.8522,000392,7002,232,963Apr 03 07:26 PM
Lian BrianPresident & CEOMar 31 '23Option Exercise9.4967,970645,0352,322,933Apr 03 07:26 PM
Lian BrianPresident & CEOMar 31 '23Sale17.4567,9701,186,0762,254,963Apr 03 07:26 PM
ZANTE GREGChief Financial OfficerMar 30 '23Option Exercise7.2993,750683,482278,807Apr 03 07:24 PM
Lian BrianPresident & CEOMar 30 '23Option Exercise2.42135,382327,8382,408,345Apr 03 07:26 PM
Mancini MariannaChief Operating OfficerMar 30 '23Option Exercise8.1236,100293,122297,995Apr 03 07:22 PM
Lian BrianPresident & CEOMar 30 '23Sale17.16153,3822,632,5162,254,963Apr 03 07:26 PM
ZANTE GREGChief Financial OfficerMar 30 '23Sale17.00131,0292,227,821147,778Apr 03 07:24 PM
Mancini MariannaChief Operating OfficerMar 29 '23Option Exercise9.1315,000136,950303,137Mar 30 09:04 PM
Mancini MariannaChief Operating OfficerMar 29 '23Sale16.0041,242659,872261,895Mar 30 09:04 PM